Cytomegalovirus infection: A driving force in human T cell immunosenescence

Annals of the New York Academy of Sciences

Volumn 1114, Issue , 2007, Pages 23-35

  Koch, Sven ^a   Larbi, Anis ^a   Özcelik, Dennis ^a   Solana, Rafael ^b   Gouttefangeas, Cécile ^a   Attig, Sebastian ^a   Wikby, Anders ^c   Strindhall, Jan ^c   Franceschi, Claudio ^d   Pawelec, Graham ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c JÖNKÖPING UNIVERSITY   (Sweden)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Aging; Cell aging; Cytology; Cytomegalovirus; Cytomegalovirus infections; Humans; Immune system; Immunity; Immunology; Longitudinal studies; Memory; Mortality; Phenotype; Risk factors; T lymphocytes; Virology

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CIDOFOVIR; CYTOMEGALOVIRUS VACCINE; FOSCARNET; GANCICLOVIR; HLA A2 ANTIGEN; T LYMPHOCYTE RECEPTOR; VALGANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN SPECIFICITY; BREAST MILK; CELL AGING; CELL FUNCTION; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOLOGY; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; HERPES VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; LONGITUDINAL STUDY; MORTALITY; PHENOTYPE; SENESCENCE; T LYMPHOCYTE; UNSPECIFIED SIDE EFFECT;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 35948988938     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1396.043     Document Type: Conference Paper

References (58)

1. WREGHITT, T.G., E.L. TEARE, O. SULE, et al. 2003. Cytomegalovirus infection in immunocompetent patients. Clin. Infect. Dis. 37: 1603-1606.
2. GALIATSATOS, P., I. SHRIER, E. LAMOUREUX & A. SZILAGYI. 2005. Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig. Dis. Sci. 50: 609-616.
3. + T cell populations reveals sustained, functional and mature responses. Immun. Ageing 3: 11.
4. OLSSON, J., A. WIKBY, B. JOHANSSON, et al. 2000. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study Mech. Ageing Dev. 121: 187-201.
5. KHAN, N., N. SHARIFF, M. COBBOLD, et al. 2002. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 169: 1984-1992.
6. WILLS, M.R., G. OKECHA, M.P. WEEKES, et al. 2002. Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response. J. Immunol. 168: 5455-5464.
7. PITTET, M.J., A. ZIPPELIUS, D.E. SPEISER, et al. 2001. Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J. Immunol. 166: 7634-7640.
8. ALTMAN, J.D., P.A. MOSS, P.J. GOULDER, et al. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
9. + T cells in aged mice. Eur. J. Immunol. 32: 1650-1658.
10. + T cells in aged mice. Ann.N.Y. Acad. Sci. 987: 274-279.
11. SALLUSTO, F., J. GEGINAT & A. LANZAVECCHIA. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
12. KOCH, S., R. SOLANA, R.O. DELA & G. PAWELEC. 2006. Human cytomegalovirus infection and T cell immunosenescence: a mini review. Mech. Ageing Dev. 127: 538-543.
13. + T subsets with distinct replicative history and partial effector functions. Blood 102: 1779-1787.
14. TOMIYAMA, H., T. MATSUDA & M. TAKIGUCHI. 2002. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype. J. Immunol. 168: 5538-5550.
15. + T cells and its implication in T-cell aging. Immunol. Rev. 205: 190-206.
16. WENG, N.P. 2006. Aging of the immune system: howmuch can the adaptive immune system adapt? Immunity 24: 495-499.
17. BANDRES, E., J. MERINO, B. VAZQUEZ, et al. 2000. The increase of IFN-gamma production through aging correlates with the expanded CD8(+high)CD28 (-)CD57(+) subpopulation. Clin. Immunol. 96: 230-235.
18. NORTHFIELD, J., M. LUCAS, H. JONES, et al. 2005. Does memory improve with age? CD85j (ILT-2/LIR-1) expression on CD8 T cells correlates with 'memory inflation' in human cytomegalovirus infection Immunol. Cell Biol. 83: 182-188.
19. + T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp. Gerontol. 38: 911-920.
20. + T cells. Exp. Gerontol. 39: 1233-1243.
21. KHAN, N., A. HISLOP, N. GUDGEON, et al. 2004. Herpesvirus-specific CD8 T Cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J. Immunol. 173: 7481-7489.
22. + T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J. Clin. Immunol. 23: 247-257.
23. OUYANG, Q., W.M. WAGNER, W. ZHENG, et al. 2004. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp. Gerontol. 39: 607-613.
24. VOEHRINGER, D., M. KOSCHELLA & H. PIRCHER. 2002. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 100: 3698-3702.
25. PAWELEC, G., S. KOCH, H. GRIESEMANN, et al. 2006. Immunosenescence, suppression and tumour progression. Cancer Immunol. Immunother. 55: 981-986.
26. + T cells. Blood 101: 2711-2720.
27. + T lymphocytes during active, latent, and resolved infection and its relation with CD57. J. Immunol. 174: 6088-6094.
28. WIKBY, A., B. JOHANSSON, J. OLSSON, et al. 2002. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp. Gerontol. 37: 445-453.
29. PAWELEC, G., A. AKBAR, C. CARUSO, et al. 2005. Human immunosenescence: is it infectious? Immunol. Rev. 205: 257-268.
30. HADRUP, S.R., J. STRINDHALL, T. KOLLGAARD, et al. 2006. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 176: 2645-2653.
31. WIKBY, A., B.O. NILSSON, R. FORSEY, et al. 2006. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech. Ageing Dev. 127: 695-704.
32. STRINDHALL, J., B.O. NILSSON, S. LOFGREN, et al. 2007. No immune risk profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp. Gerontol. May 21 [Epub ahead of print].
33. + T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202: 673-685.
34. + T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech. Ageing Dev. 124: 477-485.
35. WIKBY, A., F. FERGUSON, R. FORSEY, et al. 2005. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J. Gerontol. A Biol. Sci. Med. Sci. 60: 556-565.
36. BRYDAK, L.B., M. MACHALA, J. MYSLIWSKA, et al. 2003. Immune response to influenza vaccination in an elderly population. J. Clin. Immunol. 23: 214-222.
37. TRZONKOWSKI, P., J. MYSLIWSKA, E. SZMIT, et al. 2003. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination: an impact of immunosenescence. Vaccine 21: 3826-3836.
38. SINICCO, A., R. RAITERI, M. SCIANDRA, et al. 1997. The influence of cytomegalovirus on the natural history of HIV infection: evidence of rapid course of HIV infection in HIV-positive patients infected with cytomegalovirus. Scand. J. Infect. Dis. 29: 543-549.
39. + T cells in healthy HLA-A2+donors. Eur. J. Immunol. 35: 2876-2885.
40. KERN, F., T. BUNDE, N. FAULHABER, et al. 2002. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J. Infect. Dis. 185: 1709-1716.
41. LI, P.G., L. BOTTONE, F. IVALDI, et al. 2005. Generation of cytomegalovirus (CMV)-specific CD4 T cell lines devoid of alloreactivity, by use of a mixture of CMV-phosphoprotein 65 peptides for reconstitution of the T helper repertoire. J. Infect. Dis. 191: 215-226.
42. SESTER, M., U. SESTER, B. GARTNER, et al. 2002. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J. Virol. 76: 3748-3755.
43. + T cell clones specific for human cytomegalovirus are distributed in both CD45RAhigh and CD45ROhigh populations. J. Immunol. 173: 5843-5851.
44. APPAY, V., J.J. ZAUNDERS, L. PAPAGNO, et al. 2002. Characterization of CD4(+) CTLs ex vivo. J. Immunol. 168: 5954-5958.
45. + T lymphocytes with cellular maturation. J. Exp. Med. 203: 2865-2877.
46. +CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J. Immunol. 173: 1834-1841.
47. + T cells in healthy carriers are continuously driven to replicative exhaustion. J. Immunol. 175: 8218-8225.
48. GAMADIA, L.E., E.M. VAN LEEUWEN, E.B. REMMERSWAAL, et al. 2004. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J. Immunol. 172: 6107-6114.
49. NEWELL, M.L. 2003. Antenatal and perinatal strategies to prevent mother-to-child transmission of HIV infection. Trans. R. Soc. Trop. Med. Hyg. 97: 22-24.
50. HAMPRECHT, K., J. MASCHMANN, D. MULLER, et al. 2004. Cytomegalovirus (CMV) inactivation in breast milk: reassessment of pasteurization and freeze-thawing. Pediatr. Res. 56: 529-535.
51. BIRON, K.K. 2006. Antiviral drugs for cytomegalovirus diseases. Antiviral Res. 71: 154-163.
52. DAY, C.L., D.E. KAUFMANN, P. KIEPIELA, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
53. + T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
54. BLACKBURN, S.D. & E.J. WHERRY. 2007. IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 15: 143-146.
55. BROOKS, D.G., M.J. TRIFILO, K.H. EDELMANN, et al. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309.
56. EJRNAES, M., C.M. FILIPPI, M.M. MARTINIC, et al. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203: 2461-2472.
57. ASPINALL, R. 2006. T cell development, ageing and interleukin-7. Mech. Ageing Dev. 127: 572-578.
58. HENSON, S.M., R. SNELGROVE, T. HUSSELL, et al. 2005. An IL-7 fusion protein that shows increased thymopoietic ability. J. Immunol. 175: 4112-4118.